Translational funding opportunities

MVLS has secured approximately £2m of translational funding from the BBSRC, MRC and Wellcome Trust to help support the translation of research.  The Translational Research Initiative (TRI) coordinates access to these funds to help:

  • De-risk innovations to secure next stage grants (e.g. MRC DPFS), industry collaborations (including Innovate UK funding), or investment for spin out company formation
  • Up-skill academic researchers engaging with impact and commercialisation
  • Deepen and expand external partnerships with industry and investors
  • Develop the MVLS technology pipeline

Development grants
Through the TRI, funding is available for research projects with high potential for translation and impact.  Applicants should clearly outline the unmet need, the unique benefits of the solution, the route to market and the next steps in the translation pathway for the work to be funded.

Funding opportunties available from Wellcome ECD, MRC CiC, MRC P2D, BBSRC EwI and BBSRC IAA. 

To identify the technology readiness level (TRL) of your project and the funding opportunities available, see below. 

For more information, please watch our Applying for Translational Research Funding Video and contact Louise Mason.

TRL and funding opportunities